我院抗肿瘤中药注射剂临床药学监护路径建立初探及思考  

A Preliminary Study and Consideration on the Establishment of Clinical Pharmaceutical Care Path for Antitumor TCM Injections in Our Hospital

作　　者：戚姝娅 石亚飞 张铭予 顾琼 李璐 费小非 李国辉 QI Shu-ya;SHI Ya-fei;ZHANG Ming-yu;GU Qiong;LI Lu;FEI Xiao-fei;LI Guo-hui(National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital of Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China)

机构地区：[1]国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院药剂科,北京100021

出　　处：《海峡药学》2024年第8期78-80,共3页Strait Pharmaceutical Journal

基　　金：首都卫生发展科研专项项目(首发2022-2-4028)。

摘　　要：目的探索抗肿瘤中药注射液临床合理使用路径建立流程与方法。方法通过简单回顾我院常用抗肿瘤中药注射剂的临床合理使用路径制定过程,梳理临床药学工作要点及问题。结果形成覆盖用药全过程,分阶段设置药学监护点的临床合理用药路径制定原则。结论中药注射液临床应用整体偏灵活,且缺乏高质量循证证据,临床药师在辅助管理其合理应用时除严格按照相关指南、共识及规范制定监护要点外,还需结合医院特质灵活设置路径执行细节。OBJECTIVE To explore the process and method of establishing clinical rational use path of antitumor traditional Chinese medicine(TCM)injection.METHODS Through a brief review of the formulation process of clinical rational use of antitumor TCM injections in our hospital,the key points and problems of clinical pharmacy were sorted out.RESULTS The formulation principle of clinical rational drug use pathway covering the whole process of drug use and setting the focus of pharmaceutical care in stages was formed.CONCLUSION The overall clinical application of TCM injection is somewhat flexible and lacks high-quality evidence-based evidence.When formulating the clinical rational application path,in addition to formulating the monitoring points in strict accordance with relevant guidelines,consensus and norms,it is also necessary to flexibly set the implementation details of the path combined with the characteristics of the hospital.

关 键 词：抗肿瘤 中药注射剂 药学监护 临床路径 

分 类 号：R969.4[医药卫生—药理学]